Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium.

Ifeanyichukwu OgobuiroAmber L CollierKhadeja KhanIago de Castro SilvaDeukwoo KwonGregory C WilsonPatrick B SchwartzAlexander A ParikhChet HammillHong J KimDavid A KoobyDaniel AbbottShishir K MaithelRebecca A SnyderSyed A AhmadNipun B MerchantJashodeep Datta

Published in: Annals of surgical oncology (2022)

Black patients undergoing pancreatectomy appear less likely to experience MPR following NAT. The contribution of biologic and nonbiologic factors to reduced chemosensitivity in Black patients warrants further investigation.

Keyphrases

neoadjuvant chemotherapy
lymph node
locally advanced
patients undergoing
end stage renal disease
prognostic factors
sentinel lymph node
ejection fraction
rheumatoid arthritis
newly diagnosed
peritoneal dialysis
rectal cancer
radiation therapy
patient reported